
Leigh C. Maier
Examiner (ID: 12110, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1614, 1621, 1693 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10975376
[patent_doc_number] => 20140378411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'HYALURONIC ACID AND ITS USE FOR TREATING VENOUS INSUFFICIENCY AND VARICOSE VEINS'
[patent_app_type] => utility
[patent_app_number] => 14/367069
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7139
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367069
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/367069 | Hyaluronic acid and its use for treating venous insufficiency and varicose veins | Dec 19, 2012 | Issued |
Array
(
[id] => 8792681
[patent_doc_number] => 20130109650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'COMPOSITION CONTAINING OLIGOSACCHARIDES FOR THE TREATMENT/PREVENTION OF INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/714883
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3907
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13714883
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/714883 | COMPOSITION CONTAINING OLIGOSACCHARIDES FOR THE TREATMENT/PREVENTION OF INFECTIONS | Dec 13, 2012 | Abandoned |
Array
(
[id] => 8768256
[patent_doc_number] => 20130096293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/707290
[patent_app_country] => US
[patent_app_date] => 2012-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 98013
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707290
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707290 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY | Dec 5, 2012 | Abandoned |
Array
(
[id] => 8779704
[patent_doc_number] => 20130101679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'CHOLESTANOL DERIVATIVE FOR COMBINED USE'
[patent_app_type] => utility
[patent_app_number] => 13/705304
[patent_app_country] => US
[patent_app_date] => 2012-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4611
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13705304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/705304 | CHOLESTANOL DERIVATIVE FOR COMBINED USE | Dec 4, 2012 | Abandoned |
Array
(
[id] => 8916991
[patent_doc_number] => 20130178616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'USE OF MODIFIED OLIGO-B-(1,3)-GLUCANES FOR TREATING DISEASES OF THE IMMUNE SYSTEM OLIGO-B-(1,3V-GLUCANE-(1,3)-MANNOSE, OLIGO-B-(1,3)-GLUCANE-(1,3)-MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THE SAME AND DRUGS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 13/681132
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25934
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681132
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/681132 | USE OF MODIFIED OLIGO-B-(1,3)-GLUCANES FOR TREATING DISEASES OF THE IMMUNE SYSTEM OLIGO-B-(1,3V-GLUCANE-(1,3)-MANNOSE, OLIGO-B-(1,3)-GLUCANE-(1,3)-MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THE SAME AND DRUGS CONTAINING THEM | Nov 18, 2012 | Abandoned |
Array
(
[id] => 11331691
[patent_doc_number] => 09522928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'Mannosylated compounds useful for the prevention and the treatment of infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 14/358157
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 27453
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358157
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358157 | Mannosylated compounds useful for the prevention and the treatment of infectious diseases | Nov 13, 2012 | Issued |
Array
(
[id] => 8671443
[patent_doc_number] => 20130045981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/656785
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2484
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/656785 | ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD | Oct 21, 2012 | Abandoned |
Array
(
[id] => 9757312
[patent_doc_number] => 20140288013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE MANAGEMENT OF CANCER USING 2-DG AND AN IGF-IR INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/350817
[patent_app_country] => US
[patent_app_date] => 2012-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5417
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350817 | METHODS AND COMPOSITIONS FOR THE MANAGEMENT OF CANCER USING 2-DG AND AN IGF-IR INHIBITOR | Oct 16, 2012 | Abandoned |
Array
(
[id] => 10186783
[patent_doc_number] => 09216191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => 'Methods and composition for inducing satiety'
[patent_app_type] => utility
[patent_app_number] => 14/350819
[patent_app_country] => US
[patent_app_date] => 2012-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13153
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350819
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350819 | Methods and composition for inducing satiety | Oct 10, 2012 | Issued |
Array
(
[id] => 9786297
[patent_doc_number] => 20140303117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Method for Treating Acute Kidney Injury'
[patent_app_type] => utility
[patent_app_number] => 14/351118
[patent_app_country] => US
[patent_app_date] => 2012-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3563
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 69
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351118 | Method for treating acute kidney injury | Oct 8, 2012 | Issued |
Array
(
[id] => 9657307
[patent_doc_number] => 20140228312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'ANTIBIOTIC COMPOSITION AND ITS USES'
[patent_app_type] => utility
[patent_app_number] => 14/348971
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12006
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348971
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348971 | ANTIBIOTIC COMPOSITION AND ITS USES | Sep 30, 2012 | Abandoned |
Array
(
[id] => 9671987
[patent_doc_number] => 20140235850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'SYNTHESIS OF HMO CORE STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 14/348334
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17213
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348334
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348334 | SYNTHESIS OF HMO CORE STRUCTURES | Sep 30, 2012 | Abandoned |
Array
(
[id] => 10912763
[patent_doc_number] => 20140315781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'METHODS OF TREATING FATTY LIVER DISEASE WITH HELMINTH-DERIVED GLYCAN-CONTAINING COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/346613
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16222
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346613
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346613 | METHODS OF TREATING FATTY LIVER DISEASE WITH HELMINTH-DERIVED GLYCAN-CONTAINING COMPOUNDS | Sep 20, 2012 | Abandoned |
Array
(
[id] => 8720226
[patent_doc_number] => 20130071443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'Glycosaminoglycans'
[patent_app_type] => utility
[patent_app_number] => 13/617740
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 16725
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13617740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/617740 | Glycosaminoglycans | Sep 13, 2012 | Abandoned |
Array
(
[id] => 8670712
[patent_doc_number] => 20130045249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'Glycosaminoglycans'
[patent_app_type] => utility
[patent_app_number] => 13/603569
[patent_app_country] => US
[patent_app_date] => 2012-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 46862
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/603569 | Glycosaminoglycans | Sep 4, 2012 | Issued |
Array
(
[id] => 9375809
[patent_doc_number] => 08680073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Stable hyaluronan/steroid formulation'
[patent_app_type] => utility
[patent_app_number] => 13/593026
[patent_app_country] => US
[patent_app_date] => 2012-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 3927
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593026
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/593026 | Stable hyaluronan/steroid formulation | Aug 22, 2012 | Issued |
Array
(
[id] => 12387837
[patent_doc_number] => 09963518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Cyclic oligosaccharides for use in the treatment and prevention of bacterial infection
[patent_app_type] => utility
[patent_app_number] => 14/239826
[patent_app_country] => US
[patent_app_date] => 2012-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 10145
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239826
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239826 | Cyclic oligosaccharides for use in the treatment and prevention of bacterial infection | Aug 19, 2012 | Issued |
Array
(
[id] => 8951429
[patent_doc_number] => 20130197210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 13/586328
[patent_app_country] => US
[patent_app_date] => 2012-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 25973
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13586328
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/586328 | COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES | Aug 14, 2012 | Abandoned |
Array
(
[id] => 8698007
[patent_doc_number] => 20130060016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'GENETICALLY MODIFIED PLANTS WHICH SYNTHESIZE A LOW AMYLOSE STARCH WITH INCREASED SWELLING POWER'
[patent_app_type] => utility
[patent_app_number] => 13/585675
[patent_app_country] => US
[patent_app_date] => 2012-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29466
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13585675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/585675 | GENETICALLY MODIFIED PLANTS WHICH SYNTHESIZE A LOW AMYLOSE STARCH WITH INCREASED SWELLING POWER | Aug 13, 2012 | Abandoned |
Array
(
[id] => 8896260
[patent_doc_number] => 08475781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Cyclodextrin-based polymers for therapeutics delivery'
[patent_app_type] => utility
[patent_app_number] => 13/572243
[patent_app_country] => US
[patent_app_date] => 2012-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 37358
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13572243
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/572243 | Cyclodextrin-based polymers for therapeutics delivery | Aug 9, 2012 | Issued |